What does Jeito Capital invest in?
Jeito Capital invests most often at Series A and Series B (60% of the rounds on record), in sectors such as Healthcare and Biotech.

France · Investor
Last cheque observed Jun 2026; 5 cheques on record.
Deploying nowVC firm
Follow Jeito Capital and see its new cheques in your feed.Start following
3 cheques in the last 12 months
Mostly Series A and Series B: 60% of its rounds
Led 3 rounds
Jeito Capital is a global leading investment company with a patient benefit driven approach that finances and accelerates ground-breaking medical innovation.From their own website
Every round we can evidence, newest first5 appearances
3 rounds
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration2 named
We also hold 10 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
From their own portfolio page (on their website)
theirtheirtheirtheirtheirtheirtheirtheirtheirtheirtheirtheirtheirtheirtheirtheirtheir
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
The investors most often in the same rounds as Jeito Capital. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Jeito Capital put money into.
Jeito Capital invests most often at Series A and Series B (60% of the rounds on record), in sectors such as Healthcare and Biotech.
5 investments on record, 3 of them in the last 12 months, and it led 3. The most recent was in Jun 2026.
Its most recent investments on record: Bionyra Pharma (Series A, Jun 2026), Adcendo (Series C, Apr 2026) and Alveus Therapeutics Inc. (Series A, Feb 2026).
The median round it joins is $165M.
Yes: it led 3 of its 5 investments on record (60%).
Most of the companies it backs are in France (20%), Denmark (20%) and the United States (20%).
Yes: it is actively investing, with 3 investments in the last 12 months.
Most often Novo Holdings (3 rounds together), Avego Bioscience Capital (2 rounds together) and Bpifrance (2 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it